Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

 Regional Subscription Agents/Distributors
Trends in Photochemistry & Photobiology   Volumes    Volume 3  Issue 2
Photodynamic therapy using systemically administered 5-aminolaevulinic acid
A. J. MacRobert
Pages: 403 - 412
Number of pages: 10
Trends in Photochemistry & Photobiology
Volume 3  Issue 2

Copyright © 1994 Research Trends. All rights reserved

A new approach to photodynamic therapy (PDT) has recently been developed using the nature porphyrin precursor 5-aminolaevulinic acid (ALA) which is an intermediate in the haem biosynthetic pathway. It has been shown that using either topical or systemic administration of ALA, a transient accumulation of photoactive endogenous porphyrin species occurs which can then be exploited for photodynamic therapy. Until recently, only topically applied ALA has been used therapeutically which has restricted its use mainly to skin lesion treatment, but with systemic administration the potential clinical applications are much wider. In this article recent pre-clinical and clinical results obtained using systemically administered ALA are reviewed with the emphasis on treatment of gastrointestinal and oral cavity tumours. The use and possible limitations of ALA-induced endogenous porphyrin fluorescence as a diagnostic technique are also discussed.
Buy this Article


Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Search Products
Browse in Alphabetical Order : Journals
Browse by Subject Classification : Journals

Ordering Information Ordering Information
Downloadable forms Downloadable Forms